5801 - 5850 of 8818 Results
Title
Year
-
OPENTitle: Glycopeptide drugs: A pharmacological dimension between “Small Molecules” and “Biologics”Journal Name: PeptidesPublisher: Elsevier BVVol: 131Issue #:Start Page: 170369End Page: 170369Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.peptides.2020.170369Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7448947Citation Count: 49
-
OPENTitle: Analysis of heterozygous PRKN variants and copy number variations in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 79Issue #:Start Page: e28End Page: e28Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.123Citation Count: 6
-
RESTRICTEDTitle: White matter microstructural organizations in patients with severe treatment-resistant schizophrenia: A diffusion tensor imaging studyJournal Name: Progress in Neuro-Psychopharmacology and Biological PsychiatryPublisher: Elsevier BVVol: 100Issue #:Start Page: 109871End Page: 109871Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pnpbp.2020.109871Citation Count: 29
-
OPENTitle: Robust and facile purification of full-length, untagged human Nedd4 as a recombinant protein from Escherichia coliJournal Name: Protein Expression and PurificationPublisher: Elsevier BVVol: 173Issue #:Start Page: 105649End Page: 105649Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.pep.2020.105649Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8494286Citation Count: 3
-
RESTRICTEDTitle: Neural activity in functional movement disorders after inpatient rehabilitationJournal Name: Psychiatry Research: NeuroimagingPublisher: Elsevier BVVol: 303Issue #:Start Page: 111125End Page: 111125Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pscychresns.2020.111125Citation Count: 27
-
OPENTitle: A functionalized hydroxydopamine quinone links thiol modification to neuronal cell deathJournal Name: Redox BiologyPublisher: Elsevier BVVol: 28Issue #:Start Page: 101377End Page: 101377Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.redox.2019.101377Best OA location URL: https://doi.org/10.1016/j.redox.2019.101377Citation Count: 27
-
RESTRICTEDTitle: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&DJournal Name: Research PolicyPublisher: Elsevier BVVol: 49Issue #: 8Start Page: 104032End Page: 104032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032Citation Count: 4
-
OPENTitle: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic NeuronsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 75End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005Best OA location URL: http://www.cell.com/article/S2213671119304448/pdfCitation Count: 49
-
OPENTitle: Transdifferentiation of Mouse Embryonic Fibroblasts into Dopaminergic Neurons Reactivates LINE-1 Repetitive ElementsJournal Name: Stem Cell ReportsPublisher: Elsevier BVVol: 14Issue #: 1Start Page: 60End Page: 74Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.002Best OA location URL: http://www.cell.com/article/S2213671119304163/pdfCitation Count: 23
-
RESTRICTEDTitle: Rebooting Late-Life Mental Health Innovation and Entrepreneurship With Convergence ScienceJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 28Issue #: 6Start Page: 591End Page: 596Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.03.003Citation Count: 8
-
RESTRICTEDTitle: Recurrent neurologic symptoms complicating venom immunotherapy in a patient with systemic mastocytosis and severe Hymenoptera allergyJournal Name: The Journal of Allergy and Clinical Immunology: In PracticePublisher: Elsevier BVVol: 8Issue #: 2Start Page: 780End Page: 782Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jaip.2019.07.040Citation Count: 1
-
OPENTitle: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's DiseaseJournal Name: The American Journal of Geriatric PsychiatryPublisher: Elsevier BVVol: 29Issue #: 1Start Page: 35End Page: 47Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7671949Citation Count: 5
-
RESTRICTEDTitle: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 2Start Page: 135End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5Citation Count: 112
-
RESTRICTEDTitle: Wearable-based mobility monitoring: the long road aheadJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 5Start Page: 378End Page: 379Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30033-8Citation Count: 28
-
RESTRICTEDTitle: β-adrenoreceptors and the risk of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 3Start Page: 247End Page: 254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30400-4Citation Count: 73
-
RESTRICTEDTitle: Subthalamic nucleus deep brain stimulation with a multiple independent constant current-controlled device in Parkinson's disease (INTREPID): a multicentre, double-blind, randomised, sham-controlled studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 491End Page: 501Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30108-3Citation Count: 129
-
RESTRICTEDTitle: Multiple sclerosis in 2019: predicting progressionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 12End Page: 14Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30441-7Citation Count: 1
-
RESTRICTEDTitle: Movement disorders in 2019: from antibodies to lifestyle interventionsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 10End Page: 12Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30438-7Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133486Citation Count: 1
-
OPENTitle: A cornerstone initiative for progress in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 1End Page: 1Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6Best OA location URL: http://www.thelancet.com/article/S1474442219304326/pdfCitation Count: 1
-
OPENTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 887End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30359-8Best OA location URL: http://www.thelancet.com/article/S1474442220303598/pdfCitation Count: 2
-
OPENTitle: Patient-centred management of Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 889End Page: 890Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30360-4Best OA location URL: http://www.thelancet.com/article/S1474442220303604/pdfCitation Count: 0
-
OPENTitle: Provisional case definitions for COVID-19-associated neurological diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 890End Page: 891Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30373-2Best OA location URL: http://www.thelancet.com/article/S1474442220303732/pdfCitation Count: 7
-
RESTRICTEDTitle: Patient-centred management of Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 11Start Page: 888End Page: 889Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30355-0Citation Count: 0
-
OPENTitle: Initiating pharmacotherapy in early Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 643End Page: 644Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30225-8Best OA location URL: https://pure.amc.nl/en/publications/initiating-pharmacotherapy-in-early-parkinsons-disease(38fe3866-cce3-4a08-934a-d979a3cec1cc).htmlCitation Count: 5
-
OPENTitle: Huntington's disease in BangladeshJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 8Start Page: 644End Page: 645Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30216-7Best OA location URL: http://www.thelancet.com/article/S1474442220302167/pdfCitation Count: 1
-
OPENTitle: Long before Huntington's disease: what matters most?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 6Start Page: 473End Page: 475Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/s1474-4422(20)30156-3Best OA location URL: http://www.thelancet.com/article/S1474442220301563/pdfCitation Count: 0
- Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson Disease2020OPENTitle: Kinesthetic Cells within the Subthalamic Nucleus and Deep Brain Stimulation for Parkinson DiseaseJournal Name: World NeurosurgeryPublisher: Elsevier BVVol: 139Issue #:Start Page: e784End Page: e791Publication Date:Open Access(OA) Status: OPENLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.wneu.2020.04.160Best OA location URL: https://www.sciencedirect.com/science/article/am/pii/S187887502030869XCitation Count: 2
-
RESTRICTEDTitle: Stem-Cell Research of Parkinson Disease: Bibliometric Analysis of Research Productivity from 1999 to 2018Journal Name: World NeurosurgeryPublisher: Elsevier BVVol: 134Issue #:Start Page: e405End Page: e411Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.wneu.2019.10.087Citation Count: 13
-
OPENTitle: Anti-α-synuclein ASO delivered to monoamine neurons prevents α-synuclein accumulation in a Parkinson's disease-like mouse model and in monkeysJournal Name: eBioMedicinePublisher: Elsevier BVVol: 59Issue #:Start Page: 102944End Page: 102944Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.ebiom.2020.102944Best OA location URL: http://www.thelancet.com/article/S2352396420303200/pdfCitation Count: 63
-
OPENTitle: Not only loud but also intelligibleJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 24Issue #:Start Page: 100456End Page: 100456Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2020.100456Best OA location URL: http://www.thelancet.com/article/S2589537020302005/pdfCitation Count: 2
-
OPENTitle: Treatment Stratification of Patients with Metastatic Castration-Resistant Prostate Cancer by Machine LearningJournal Name: iSciencePublisher: Elsevier BVVol: 23Issue #: 2Start Page: 100804End Page: 100804Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.isci.2019.100804Best OA location URL: https://doi.org/10.1016/j.isci.2019.100804Citation Count: 19
-
OPENTitle: The Future of GDNF in Parkinson's DiseaseJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2020.593572Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2020.593572/pdfCitation Count: 43
-
OPENTitle: The Impact of COVID-19 on Neurology Education: A Medical Student PerspectiveJournal Name: Frontiers in EducationPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/feduc.2020.567421Best OA location URL: https://www.frontiersin.org/articles/10.3389/feduc.2020.567421/pdf?isPublishedV2=FalseCitation Count: 6
-
OPENTitle: Kinase Domain Is a Dynamic Hub for Driving LRRK2 AllosteryJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2020.538219Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2020.538219/pdfCitation Count: 24
-
OPENTitle: Genetic Architecture of Parkinson's Disease in the Indian Population: Harnessing Genetic Diversity to Address Critical Gaps in Parkinson's Disease ResearchJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00524Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00524/pdfCitation Count: 35
-
OPENTitle: Parkinson's Disease Research on the African Continent: Obstacles and OpportunitiesJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 11Issue #:Start Page: 512End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2020.00512Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2020.00512/pdfCitation Count: 34
-
OPENTitle: LRRK2 and α-Synuclein: Distinct or Synergistic Players in Parkinson’s Disease?Journal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page: 577End Page: 577Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00577Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00577/pdfCitation Count: 70
-
OPENTitle: Editorial: Protein Degradation Pathways in Parkinson's Disease and NeurodegenerationJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2020.00741Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2020.00741/pdfCitation Count: 0
-
RESTRICTEDTitle: Tears – More to Them Than Meets the Eye: Why Tears Are A Good Source of Biomarkers in Parkinson'S DiseaseJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 14Issue #: 2Start Page: 151End Page: 163Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm-2019-0364Citation Count: 19
-
OPENTitle: Application of the ‘5-2-1’ Screening Criteria in Advanced Parkinson’s Disease: Interim Analysis of DUOGLOBEJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 10Issue #: 5Start Page: 309End Page: 323Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.2217/nmt-2020-0021Best OA location URL: https://kclpure.kcl.ac.uk/portal/en/publications/17e77252-07a9-4a0c-bf27-17619e38abb5Citation Count: 45
-
RESTRICTEDTitle: Effects of a community-based Exercise Program On mobility, balance, cognition, sleep, Activities of Daily living, and Quality of Life in PD: A Pilot StudyJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 10Issue #: 1Start Page: 27End Page: 39Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2019-0027Citation Count: 19
-
OPENTitle: Parkinson disease with mild cognitive impairment: Domain‐specific cognitive complaints predict dementiaJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 142Issue #: 6Start Page: 585End Page: 596Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13326Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ane.13326Citation Count: 10
-
OPENTitle: Physical activity and cognition in young‐onset Parkinson’s diseaseJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 142Issue #: 2Start Page: 151End Page: 160Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.13256Citation Count: 13
-
OPENTitle: Microgravity: A Tool for Protein Drug DevelopmentJournal Name: International Journal of Pharmaceutical Sciences Review and ResearchPublisher: Global Research OnlineVol: 64Issue #: 2Start Page: 82End Page: 86Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.47583/ijpsrr.2020.v64i02.014Best OA location URL: https://doi.org/10.47583/ijpsrr.2020.v64i02.014Citation Count: 5
-
RESTRICTEDTitle: Telemedicine in Movement Disorders: Leçons du COVID‐19Journal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 1893End Page: 1896Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28297Citation Count: 28
-
OPENTitle: Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic PerformanceJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 12Start Page: 2301End Page: 2313Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28263Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28263Citation Count: 35
-
RESTRICTEDTitle: Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective StudyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 750End Page: 757Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28320Citation Count: 46
-
OPENTitle: The Parkinson's Disease Genome‐Wide Association Study Locus BrowserJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2056End Page: 2067Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28197Best OA location URL: https://pub.dzne.de/search?p=id:%22DZNE-2021-00254%22Citation Count: 92
-
RESTRICTEDTitle: Spinal Cord Stimulation for Very Advanced Parkinson's Disease: A 1‐Year Prospective TrialJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 6Start Page: 1082End Page: 1083Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28065Citation Count: 30
-
OPENTitle: Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 InhibitionJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 760End Page: 773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27994Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8167931Citation Count: 89